International Journal of Drug Policy
Volume 20, Issue 1 , Pages 90-92 , January 2009

Fentanyl use among street drug users in Toronto, Canada: Behavioural dynamics and public health implications

  • Michelle Firestone

      Affiliations

    • Centre for Addiction and Mental Health, Toronto, Canada
  • ,
  • Brian Goldman

      Affiliations

    • Mount Sinai Hospital, Toronto, Canada
    • University of Toronto, Toronto, Canada
  • ,
  • Benedikt Fischer

      Affiliations

    • Centre for Addiction and Mental Health, Toronto, Canada
    • University of Toronto, Toronto, Canada
    • Centre for Addictions Research of British Columbia, Victoria, Canada
    • Corresponding Author InformationCorresponding author at: CARBC, University of Victoria, P.O. Box 1700 STN CSC, Victoria, BC V8W 2Y2, Canada. Tel.: +1 250 472 5445; fax: +1 250 472 5321.

Received 20 November 2007 ,Revised 27 February 2008 ,Accepted 28 February 2008.

References 

  1. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence. 2006;81:103–107
  2. Fischer, B., Gittins, J., & Rehm, J. (in press). Characterizing the ‘awakening elephant’ of prescription opioid misuse in North America: Epidemiology, harms, interventions. Contemporary Drug Problems.
  3. Fischer B, Popova L, Rehm J, Ivsins A. Drug use related overdose mortality in British Columbia and Ontario, 1992–2002. Canadian Journal of Public Health. 2006;95:384–387
  4. Fischer B, Rehm J. Illicit opioid use in the 21st century: Witnessing a paradigm shift. Addiction. 2007;102:499–501
  5. Fischer B, Rehm J, Patra J, Firestone Cruz M. Changes in illicit opioid use profiles across Canada. Canadian Medical Association Journal. 2006;175:1–3
  6. Gilson A, Ryan K, Jonsson D, Dahl J. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control. Journal of Pain and Symptom Management. 2004;28:176–188
  7. Havens J, Walker R, Leukefeld C. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug and Alcohol Dependence. 2007;87:98–102
  8. Hurwitz W. The challenge of prescription drug misuse: A review and commentary. Pain Medicine. 2005;6:152–161
  9. International Narcotics Control Board . Narcotic drugs: Estimated world requirements for 2007: Statistics for 2005. New York: INCB; 2006;
  10. Kronstrand R, Druid H, Holmgren P, Rajs J. A cluster of fentanyl-related deaths among addicts in Sweeden. Forensic Science International. 1997;88:185–195
  11. Kuhlman JJ, McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse and abuse: A summary of 23 postmortem cases. Journal of Analytical Toxicology. 2003;27:499–504
  12. Lehmann KA, Zech D. Transdermal fentanyl: Clinical pharmacology. Journal of Pain and Symptom Management. 1992;7:S8–S16
  13. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: Toxicological findings and circumstances of death in 112 cases (2002–2004). Journal of Analytical Toxicology. 2006;30:603–610
  14. Mathei C, Shkedy Z, Denis B, Kabali C, Aerts M, Molenberghs G. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. Journal of Viral Hepatology. 2006;13:560–570
  15. Paulozzi L, Budnitz D, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety. 2006;15:618–627
  16. Reeves MD, Ginifer CJ. Fatal intravenous misuse of transdermal fentanyl. Medical Journal of Australia. 2002;177:552–553
  17. Sung HE, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: Trends and correlates. Journal of Adolescent Health. 2005;37:44–51
  18. Tharp AM, Winecher RE, Winston D. Fatal intravenous fentanyl abuse: Four cases involving extratction of fentanyl from transdermal patches. American Journal of Forensic Medical Pathology. 2004;25:178–181
  19. Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology. 2002;155:645–653

PII: S0955-3959(08)00093-5

doi: 10.1016/j.drugpo.2008.02.016

International Journal of Drug Policy
Volume 20, Issue 1 , Pages 90-92 , January 2009